GlucoTrack (GCTK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 Aug, 2026Executive summary
Special Meeting of Stockholders scheduled for September 11, 2026, with a focus on ensuring all shareholders vote their shares.
Voting can be completed by telephone, online, or by mail, with instructions provided to shareholders.
Shareholders with multiple accounts are reminded to vote all accounts separately.
Voting matters and shareholder proposals
Shareholders are urged to vote on matters presented at the Special Meeting, with emphasis on the importance of each vote.
Proxy solicitation firm Sodali & Co. is available to assist shareholders with voting questions.
Partial view of Summaries dataset, powered by Quartr API
Latest events from GlucoTrack
- Complex capital raise with major dilution and compliance risks, targeting OA, MS, and diabetes markets.GCTK
Registration filing - Stockholders approved two major stock issuance proposals, both meeting NASDAQ compliance.GCTKAGM 2026
- All director nominees and key proposals, including reverse split and warrant inducement, were approved.GCTKAGM 2026
- Net loss narrowed, but liquidity and Nasdaq listing risks persist after Lokahi merger and new financings.GCTKQ2 2026
- Shareholders to vote on major stock issuances and adjournment, with Board recommending approval.GCTKProxy filing
- Approval sought for two large stock issuances and adjournment, with board support for all.GCTKProxy filing
- Shareholders will vote on director elections, executive pay, a reverse stock split, and warrant inducement.GCTKProxy filing
- Shareholders will vote on director elections, executive pay, a reverse split, and warrant inducement.GCTKProxy filing
- Net loss narrowed, IDE submitted, but liquidity and Nasdaq risks threaten operations.GCTKQ1 2026